Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06854458 · ClinicalTrials.gov registry record · NA
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study
A NA study of Ischemic Heart Disease (IHD) and Cardiac Magnetic Resonance Imaging, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 7
- Study locations
NCT06854458 is a NA study of Ischemic Heart Disease (IHD) and Cardiac Magnetic Resonance Imaging that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 1,000 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT06854458, a NA study of Ischemic Heart Disease (IHD) and Cardiac Magnetic Resonance Imaging, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
This research aims to investigate whether symptoms of chest pain or shortness of breath among the study population are arising due to a heart problem, particularly any reduction of blood flow to the heart muscle from blockages in the coronary blood vessels or inflammation of the heart using cardiac magnetic resonance imaging that measures the amount of blood flow during a stress state meant to simulate vigorous exercise. At present, doctors use standard magnetic resonance imaging pictures of blood flow patterns to treat heart disease. The investigators want to study if detailed blood flow measurements, in addition to the standard blood flow pattern, could diagnose heart disease more accurately and allow more doctors to understand the severity of heart disease. Early research has demonstrated that detailed blood flow measurements may be more accurate in diagnosing heart disease in some patients, but doctors need more information to know how to use these measurements.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood draw for the laboratory assessment
- DIAGNOSTIC_TEST Quantitative Myocardial Blood Flow Evaluation
- DIAGNOSTIC_TEST Qualitative Myocardial Blood Flow Evaluation
- DRUG Gadavist
- DRUG Vasodilator
Study Locations (7)
Massachusetts
- Brigham and Women's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
California
- University of California San Francisco - San Francisco
North Carolina
- Atrium Health - Sanger Heart & Vascular Institute - Charlotte
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- Houston Methodist Hospital - Houston
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-06-27 |
| Est. Completion | 2029-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06854458
The ClinicalTrials.gov registry entry for NCT06854458 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ischemic Heart Disease (IHD) appearing as the primary indexed condition, and to 5 interventions - of which Blood draw for the laboratory assessment is the first listed.
NCT06854458 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Massachusetts, California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06854458 about?
NCT06854458 is a clinical study titled "The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study". This research aims to investigate whether symptoms of chest pain or shortness of breath among the study population are arising due to a heart problem, particularly any reduction of blood flow to the heart muscle from blockages in the coronary blood vessels or inflammation of the heart using cardiac ...
What is the current status of trial NCT06854458?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-06-27. Estimated completion is 2029-03.
What conditions does trial NCT06854458 study?
This clinical trial studies the following conditions: Ischemic Heart Disease (IHD), Cardiac Magnetic Resonance Imaging, Myocardial Blood Flow.
What interventions are being tested in trial NCT06854458?
The interventions under investigation include: Blood draw for the laboratory assessment (DIAGNOSTIC_TEST), Quantitative Myocardial Blood Flow Evaluation (DIAGNOSTIC_TEST), Qualitative Myocardial Blood Flow Evaluation (DIAGNOSTIC_TEST), Gadavist (DRUG), Vasodilator (DRUG).
Who is sponsoring clinical trial NCT06854458?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06854458 being conducted?
This trial has 7 study locations across California, Massachusetts, North Carolina, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Heart Disease (IHD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Ischemic Heart Disease (IHD)
All registered trials for this condition
Cardiac Magnetic Resonance Imaging
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.